Trial Information
Clinical and Pathologic Studies in Neuroendocrine Tumors
Inclusion Criteria:
- Patients are eligible if they have a histologically proven
neuroendocrine tumor and are 18 years of age or older
- Ability to understand and the willingness to sign a written informed consent document.
Exclusion Criteria:None
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
George Albert Fisher M.D. Ph.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Stanford University
Authority:
USA:IRB
Study ID:
SU-12102007-931
NCT ID:
NCT00657332
Start Date:
July 2007
Completion Date:
June 2008
Related Keywords:
- Carcinoid Tumor
- Neuroendocrine Tumors
- Carcinoid Tumor
- Neuroendocrine Tumors
Name | Location |
Stanford University School of Medicine |
Stanford, California 94305-5317 |